Cytosorbents

CTSO

NASDAQHealth Care

Income Statement

Total Revenue$32.97M

Gross Profit$25.4M

Operating Income$-17.1M

EBITDA$-19.58M

EBIT$-21.33M

Pre-tax Income$-12.25M

Net Income$-21.03M

Cash Equivalent$11.74M

Total Debt$24.1M

Book Value$14.94M

Book Value Per Share0.27

Return on Equity (ROE)-186.54%

Return on Assets (ROA)-43.74%

Return on Invested Capital (ROI)-82.53%

Net Profit Margin-58.21%

Current Ratio2.20

Quick Ratio1.59

Long-Term Debt / Equity1.26